Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Study Director
Takeda
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queensland Childrens Hospital
South Brisbane, Queensland, Australia
Anita InwoodAvailable
- Instituto Nacional de Pediatria
Coyoacán, Mexico City, Mexico
Matilde Ruiz-GarciaAvailable - H.C.U. de Valladolid
Valladolid, Mexico
Margarita Castro ReyAvailable
- Hospital Universitario Reina Sofia
Córdoba, Spain
Mercedes Gil CamposAvailable
- Royal Manchester Children'S Hospital - Ppds
Manchester, United Kingdom
Simon JonesAvailable
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
Jasmine KnollAvailable - the Regents of the University of California
Oakland, California, United States
Paul HarmatzAvailable - the Nemours Foundation
Wilmington, Delaware, United States
Jeffery CampbellAvailable - Jackson Memorial Hospital University of Miami
Miami, Florida, United States
Willa ThorsonAvailable - Ann and Robert H Lurie Childrens Hospital of Chicago
Chicago, Illinois, United States
Barbara BurtonAvailable - Washington University
Washington, Missouri, United States
Dorothy GrangeAvailable - Board of Regents of the University of Nebraska
Omaha, Nebraska, United States
William RizzoAvailable - Joseph M. Sanzari Children'S Hospital
Hackensack, New Jersey, United States
Helio PedroAvailable - Nyu Langone Medical Center
New York, New York, United States
Devorah SegalAvailable - the University of North Carolina
Chapel Hill, North Carolina, United States
Joesph MuenzerAvailable - the Cleveland Clinic Foundation
Cleveland, Ohio, United States
Rabi HannaAvailable - Randall Children'S Hospital at Legacy Emanuel
Portland, Oregon, United States
George AnadiotisAvailable - the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Can FiciciogluAvailable - Upmc Childrens Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Damara OrtizAvailable - Vanderbilt Children'S Hospital
Nashville, Tennessee, United States
Neena AgrawalAvailable - Division of Medical Genetics, University of Utah
Salt Lake City, Utah, United States
David ViskochilAvailable - Seattle Children'S Hospital - Pin
Seattle, Washington, United States
Emily ShelkowitzAvailable
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 13 Apr 2026
- Registered enrollment
- —
- Registry id
- NCT05795361
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.